Myocardial velocity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy  by Kato, Tomoko et al.
Hypertrophic Cardiomyopathy
Myocardial Velocity Gradient as a
Noninvasively Determined Index of
Left Ventricular Diastolic Dysfunction
in Patients With Hypertrophic Cardiomyopathy
Tomoko Kato, MD,*† Akiko Noda, PHD,‡ Hideo Izawa, MD, PHD,§ Takao Nishizawa, MD,*
Fuji Somura, MD, PHD,§ Akira Yamada, MD,§ Kohzo Nagata, MD, PHD,§
Mitsunori Iwase, MD, PHD, FACC,‡ Akimasa Nakao, MD, PHD,† Mitsuhiro Yokota, MD, PHD, FACC*
Nagoya, Japan
OBJECTIVES We investigated the utility of the peak negative myocardial velocity gradient (MVG) derived
from tissue Doppler imaging (TDI) for evaluation of diastolic dysfunction in patients with
hypertrophic cardiomyopathy (HCM).
BACKGROUND Hypertrophic cardiomyopathy is characterized by impaired diastolic function with abnormal
stiffness and prolonged relaxation. However, it remains difficult to evaluate these defects
noninvasively.
METHODS Both TDI and conventional echocardiography were performed in 36 patients with HCM and
in 47 control subjects. Left ventricular (LV) pressure was measured simultaneously in all
HCM patients and in 26 controls.
RESULTS The peak negative MVG occurred soon after the isovolumic relaxation period during the
initial phase of rapid filling (auxotonic relaxation). It was significantly smaller in HCM
patients than in control subjects (2.32  0.52/s vs. 4.82  1.15/s, p  0.0001); the cutoff
value for differentiation between all HCM patients and 47 normal individuals was determined
as 3.2/s. Both the left ventricular end-diastolic pressure (LVEDP) (19.6 6.1 mm Hg vs. 6.5
 1.7 mm Hg, p  0.0001) and the time constant of LV pressure decay during isovolumic
diastole (tau) (44.0 6.7 ms vs. 32.1 5.5 ms, p 0.0001) were increased in HCM patients
compared with controls. The peak negative MVG was negatively correlated with both
LVEDP (r  0.75, p  0.0001) and tau (r  0.58, p  0.0001).
CONCLUSIONS A reduced peak negative MVG reflects both prolonged relaxation and elevated LVEDP. The
peak negative MVG might thus provide a noninvasive index of diastolic function, yielding
unique information about auxotonic relaxation in patients with HCM. (J Am Coll Cardiol
2003;42:278–85) © 2003 by the American College of Cardiology Foundation
Diastolic dysfunction is an important feature of the patho-
physiology of hypertrophic cardiomyopathy (HCM), which
is characterized by abnormal stiffness of the left ventricle
and consequent impaired ventricular filling and prolonged
relaxation (1). These abnormalities result in an increased left
ventricular end-diastolic pressure (LVEDP), pulmonary
congestion, and dyspnea, which are the most common
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symptoms of HCM. However, precise indexes for assess-
ment of diastolic function in individuals with HCM have
not been established. A diagnosis of diastolic dysfunction
requires evidence of abnormal left ventricular (LV) relax-
ation and filling, diastolic distensibility, and diastolic stiff-
ness (2). Conventional clinical evaluation of LV relaxation
involves determination of the peak negative dP/dt (first
derivative of left ventricular pressure) or the time constant of
left ventricular pressure decay (tau). The LV diastolic
distensibility and stiffness, which lead to an increased
LVEDP or pulmonary venous pressure, are evaluated by
assessment of the pressure-volume curve through an inva-
sive procedure. Although Doppler echocardiography has
been widely used for noninvasive assessment of diastolic
function, both the reliability and the reproducibility of this
approach remain controversial given that LV filling patterns
are influenced by preload (3,4).
Tissue Doppler imaging (TDI) allows quantitative as-
sessment of regional wall motion and intramural myocardial
velocity by detecting successive phase shifts of the ultra-
sound signal reflected from the myocardium throughout the
cardiac cycle (5–7). The myocardial velocity gradient
(MVG) derived from TDI was introduced as an ultrasound
index of myocardial function that is independent of trans-
lational motion (8,9). The MVG is defined as the difference
in myocardial velocity between the endocardium and the
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epicardium divided by myocardial wall thickness, and there-
fore it reflects the dynamics of myocardial thickening and
thinning (8–10).
The peak negative MVG provides an accurate estimate of
LV relaxation (11–13) and, unlike conventional Doppler
echocardiography, appears to be relatively insensitive to the
effects of preload alterations (11,12,14). However, its clin-
ical implications and reliability as an indicator of LV
diastolic function remain to be elucidated. We therefore
investigated the relation between peak negative MVG and
LV diastolic performance in patients with HCM.
METHODS
Study group. We studied 36 patients (34 men, 2 women)
with newly diagnosed nonfamilial, nonobstructive HCM,
with a mean age of 54  11 years (range 35 to 72 years).
The diagnosis was based on conventional echocardiographic
demonstration of a nondilated, hypertrophied left ventricle
without evidence of LV outflow tract obstruction and in the
absence of other cardiac or systemic diseases that might lead
to LV hypertrophy (15); it was confirmed by cardiac
catheterization, angiography, and endomyocardial biopsy.
All patients were in normal sinus rhythm and had a normal
LV ejection fraction as revealed by left ventriculography.
The control group consisted of 47 subjects (40 men, 7
women; mean age 39  18 years; range 22 to 78 years) with
normal electrocardiograms (ECG) or nonspecific ST-T
changes and with normal conventional echocardiograms.
We excluded patients with localized asynergy revealed by
conventional two-dimensional echocardiograms or left
ventriculography.
In a subset of 26 age-matched controls (24 men, 2
women; mean age 52  14 years; range 26 to 78 years),
cardiac catheterization was performed for evaluation of
atypical chest pain or discomfort. These individuals had
normal left ventriculograms and did not have valvular heart
disease or a 50% narrowing of the coronary arteries as
revealed by coronary angiography. Therefore, they were
classified as normal subjects.
All drugs were discontinued at least four days before
subject evaluation. The study was approved by the appro-
priate institutional review committee. Subjects were in-
formed in detail of the purpose and methods of the study,
and they provided written informed consent.
Cardiac catheterization. Subjects received 5 mg of oral
diazepam before catheterization. A 6F pigtail angiographic
high-fidelity micromanometer-tipped catheter (model
SPC-464D, Millar Instruments, Houston, Texas) was ad-
vanced into the left ventricle through the right brachial
artery for measurement of LV pressure. The micromanom-
eter pressure was matched to the pressure of the fluid-filled
lumen. A 21-gauge catheter was placed in the left brachial
artery for arterial pressure measurements. To measure pul-
monary artery wedge pressure (PAWP) and cardiac output,
we positioned a 7F triple-lumen thermistor Swan-Ganz
catheter (Baxter Healthcare, Deerfield, Illinois) in the
pulmonary artery through the right brachial vein. A PAWP
transducer (model 746, Siemens Medical Systems, Solna,
Sweden) was placed at the zero reference point at the
midchest level. The ECGs were recorded with the Mason
Liker modification of the standard 12-lead ECG. We
recorded micromanometer pressure signals and ECGs si-
multaneously and continuously with a multichannel re-
corder (MR-40, TEAC, Tokyo, Japan). All subjects under-
went selective coronary angiography, left ventriculography,
and endomyocardial biopsy.
Standard echocardiography and TDI. Standard echocar-
diography, including measurement of transmitral flow ve-
locity indexes, was performed with a Powervision 8000
ultrasonoscope (Toshiba Medical Systems, Tochigi, Japan),
and images were recorded on 0.5-inch videotape with VHS
recorders. Septal and posterior wall thickness and LV
end-diastolic and -systolic dimensions were measured, and
LV fractional shortening was determined from LV M-mode
recordings. Echocardiographic LV mass was calculated by
the area-length method as recommended by the American
Society of Echocardiography (16). The LV mass index was
calculated by dividing the LV mass by body surface area.
Peak early and late transmitral filling velocities, the decel-
eration time of peak early velocity, and the isovolumic
relaxation time were measured from mitral inflow velocities.
On completion of the standard echocardiographic measure-
ments, TDI was performed to obtain peak negative MVG.
Two examiners who were unaware of the clinical status of
the subject performed the echocardiographic analysis. Rep-
resentative recordings of the ECG, LV pressure, and dP/dt
together with M-mode echocardiograms and TDI for an
HCM patient are shown in Figure 1.
Data analysis. The LV pressure signals were digitized and
analyzed with software developed in our laboratory and a
32-bit microcomputer system (PC-9821-ST20, NEC, To-
kyo, Japan) (17). We calculated the peak positive dP/dt as
an index of contractility. To evaluate LV isovolumic relax-
ation, we calculated tau in two different ways. The first
approach was based on the direct measurement of the
pressure half-time (T1/2) as described by Mirsky (18); this
parameter was computed for each acquisition as the time
Abbreviations and Acronyms
dP/dt  first derivative of left ventricular pressure
ECG  electrocardiogram
HCM  hypertrophic cardiomyopathy
LV  left ventricular
LVEDP  left ventricular end-diastolic pressure
MVG  myocardial velocity gradient
PAWP  pulmonary artery wedge pressure
tau  time constant of left ventricular pressure
decay
TDI  tissue Doppler imaging
TD  tau determined by the derivative method
T1/2  tau determined by the pressure half-time
method
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required for the pressure at the time of peak negative dP/dt
to decrease by 50% of its value. The second approach was
based on that described by Raff and Glantz (19), in which
tau (TD) is determined from the negative inverse slope of
the relation between LV pressure and dP/dt. Pressure data
from that at peak negative dP/dt to a value 5 mm Hg greater
than the previous LVEDP were used for this calculation.
Calculation of MVG in M-mode TDI. The angle of
interrogation of the M-mode beam was aligned to be
perpendicular to the LV posterior wall in long-axis view.
Figure 1. Examples of posterior wall myocardial velocity gradient (MVG) (top), tissue Doppler imaging (TDI) M-mode images (middle), and
corresponding transmitral flow velocity patterns (bottom) with electrocardiograms (ECG), phonocardiograms (PCG), tracings of left ventricular pressure
(LVP), and first derivative of left ventricular pressure for a representative patient with hypertrophic cardiomyopathy. The arrow and blue line indicate the
period of peak negative MVG. The peak negative MVG for this patient was 2.12/s.
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Freeze-frame images of conventional gray-scale and the
corresponding color-coded velocity mapping images in a
bidirectional red-and-blue mode were then downloaded to a
magneto-optic disk and transferred to an IBM-compatible
computer for off-line analysis of myocardial velocities and
gradient by custom-made software (PowerView, Toshiba
Medical Systems, Tochigi, Japan), as previously described
(11,14,20). Velocity ranges were adjusted to maximize the
sensitivity for low-velocity values while avoiding saturation
of the highest velocity during diastole. Use of M-mode TDI
yielded a temporal resolution of as high as 4 ms.
With M-mode TDI, endocardial and epicardial velocities
were calculated within the posterior wall. The MVG was
defined as the slope of a linear regression of the myocardial
velocity profile along each M-mode scan line throughout
the myocardium, which reflects the dynamics of wall thick-
ening and thinning (8,9). The MVG calculations were
repeated at each time point throughout the cardiac cycle.
Peak negative MVG in early diastole was subsequently
determined and was averaged for three consecutive beats.
Statistical analysis. Data are presented as means  SD.
Normality was evaluated by normal distribution plots and
histograms for the variable. Characteristics and hemody-
namic variables were compared between groups by the
Student unpaired two-tailed t test. The relations between
peak negative MVG and hemodynamic variables were
analyzed with the use of the Pearson correlation coefficient.
A p value of 0.05 was considered statistically significant.
The cutoff value of the peak negative MVG for differenti-
ation between HCM patients and 47 normal individuals
was determined with the use of a receiver-operating char-
acteristic curve. The sensitivity [true positive/(true positive
 false negative)], specificity [true negative/(true negative
 false positive)], and predictive accuracy [(true positive 
true negative)/total group] were determined and expressed
as percentages.
RESULTS
Age and gender distribution did not differ between patients
with HCM and the subset of controls subjected to cardiac
catheterization (Table 1). Variables of noninvasive and
invasive parameters were normally distributed. The peak
negative MVG was significantly smaller in HCM patients
than in the entire control group (2.32  0.52/s vs. 4.82 
1.15/s, p  0.0001) (Fig. 2) or in controls subjected to
catheterization (Table 1). Neither LV fractional shortening,
transmitral flow indexes, the deceleration time of peak early
velocity, nor the isovolumic relaxation time differed signif-
icantly between patients with HCM and controls. The
cutoff value of normal peak negative MVG was 3.2/s and
was used to differentiate between 47 normal individuals and
HCM patients, yielding sensitivity, specificity, and predic-
tive accuracy values of 97.2% (35 of 36 subjects), 95.7% (45
of 47 subjects), and 96.4% (80 of 83 subjects), respectively.
Simultaneous recording of LV pressure and LV dP/dt by
cardiac catheterization together with the M-mode TDI
revealed that the period of peak negative MVG corre-
sponded to the initial phase of rapid filling after isovolumic
relaxation (Fig. 1); that is, the peak negative MVG coin-
cided with the process of auxotonic relaxation during LV
filling with variable LV pressure. Heart rate, cardiac index,
and LV peak positive dP/dt did not differ significantly
between HCM patients and control subjects (Table 1). The
LVEDP, PAWP, and tau (both T1/2 and TD) were signif-
icantly increased in HCM patients compared with controls.
Correlation analysis with the Pearson correlation coeffi-
cient revealed that the peak negative MVG was inversely
correlated with LVEDP (r  0.75, p  0.0001 [Fig. 3]),
PAWP (r  0.70, p  0.0001 [Fig. 4]), and tau (T1/2, r
0.58, p 0.0001 [Fig. 5]; TD, r0.64, p 0.0001).
Evaluation of data from HCM patients alone revealed that
the peak negative MVG was also significantly correlated
with LVEDP (r  0.52, p  0.001), PAWP (r  0.59,
p  0.0001), and tau (T1/2, r  0.47, p  0.003; TD, r 
0.39, p  0.02). None of the other echocardiographic
indexes, including conventional Doppler indexes, correlated
significantly with hemodynamic variables.
Table 1. Characteristics, Hemodynamic Variables, Conventional
Echocardiographic Data Including Doppler Indexes, and TDI






(n  26) p Value
Age (yrs) 54  11 52  14 NS
Male subjects (%) 94.4 92.3 NS
BSA (m2) 1.73  0.22 1.72  0.18 NS
LVDd (mm) 48.2  5.7 46.8  4.8 NS
LVDs (mm) 30.4  6.7 28.9  4.5 NS
IVST (mm) 16.6  3.6 10.1  1.6 0.0001
PWT (mm) 11.1  1.8 9.7  0.9 0.01
LVMI (g/m2) 198.6  49.9 119.6  29.2 0.0001
FS (%) 37.4  7.3 38.5  5.6 NS
Peak E velocity (cm/s) 66.3  14.3 74.3  17.5 NS
Peak A velocity (cm/s) 74.0  16.1 68.7  13.9 NS
E/A velocity ratio 0.9  0.35 1.1  0.38 NS
IRT (ms) 119.0  14.0 91.0  22.3 NS
DcT (ms) 226.8  30.7 180.7  29.8 NS
Peak negative MVG (/s) 2.2  0.52 4.8  1.22 0.0001
Heart rate (beats/min) 66  8.6 64  11.4 NS
CI (l/min per m2) 3.0  0.5 2.8  0.6 NS
PAWP (mm Hg) 14.1  4.3 7.3  2.8 0.0001
LVEDP (mm Hg) 19.6  6.1 6.5  1.7 0.0001
Peak  dP/dt (mm Hg/s) 1705  438 1912  436 NS
Peak  dP/dt (mm Hg/s) 1637  457 1890  302 NS
T1/2 (ms) 44.0  6.7 32.1  5.5 0.0001
TD (ms) 57.6  14.9 37.1  5.7 0.0001
Data are means  SD.
BSA  body surface area; CI  cardiac index; DcT  deceleration time of E
velocity; dP/dt  first derivative of left ventricular pressure; FS  fractional
shortening; IRT  isovolumic relaxation time; IVST  thickness of interventricular
septum; LVDd  left ventricular end-diastolic internal dimension; LVDs  left
ventricular end-systolic internal dimension; LVEDP  left ventricular end-diastolic
pressure; LVMI  left ventricular mass index; MVG  myocardial velocity gradient;
PAWP  pulmonary artery wedge pressure; Peak A velocity  peak late transmitral
filling velocity; Peak E velocity  peak early transmitral filling velocity; PWT 
thickness of left ventricular posterior wall; T1/2 and TD  tau calculated by direct
pressure half-time method and derivative method, respectively.
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DISCUSSION
We have shown that (1) the period of peak negative MVG
corresponds to the process of auxotonic relaxation during the
initial phase of rapid filling associated with variable LV
pressure that follows isovolumic relaxation; (2) the peak neg-
ative MVG is inversely correlated with LVEDP, PAWP, and
tau; (3) the peak negative MVG is significantly reduced in
patients with HCM compared with controls; and (4) the cutoff
value for normal peak negative MVG was 3.2/s. Determina-
tion of peak negative MVG by the noninvasive technique of
TDI thus provides an estimate of the increase in LVEDP as
well as the prolongation of tau in HCM patients.
Figure 2. Comparison of peak negative myocardial velocity gradient (MVG) between hypertrophic cardiomyopathy (HCM) patients and control sub-
jects.
Figure 3. Correlation between peak negative myocardial velocity gradient (MVG) and left ventricular end-diastolic pressure (LVEDP) for all individuals
subjected to cardiac catheterization (solid line; closed and open circles represent hypertrophic cardiomyopathy (HCM) patients and controls, respectively)
and for HCM patients alone (dotted line).
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Peak negative MVG during the cardiac cycle. Measure-
ments of diastolic function can be divided into those that
reflect the process of active relaxation and those that reflect
passive stiffness. This division is somewhat arbitrary, how-
ever, given that structures and processes affecting relaxation
can also result in measurable abnormalities in stiffness (21).
At the chamber level, the diastolic process results in a
reduction in LV pressure at a constant volume (isovolumic
relaxation), which is followed by LV filling at variable LV
pressures (auxotonic relaxation). Consequently, it is essen-
Figure 4. Correlation between peak negative myocardial velocity gradient (MVG) and pulmonary artery wedge pressure (PAWP) for all individuals
subjected to cardiac catheterization (solid line; closed and open circles represent hypertrophic cardiomyopathy (HCM) patients and controls, respectively)
and for HCM patients alone (dotted line).
Figure 5. Correlation between peak negative myocardial velocity gradient (MVG) and tau determined by the derivative method (T1/2) for all individuals
subjected to cardiac catheterization (solid line; closed and open circles represent hypertrophic cardiomyopathy (HCM) patients and controls, respectively)
and for HCM patients alone (dotted line).
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tial to quantify LV performance, including both active
relaxation and passive stiffness, in order to assess diastolic
dysfunction accurately. We now show that the period of
peak negative MVG corresponds to auxotonic relaxation,
the initial phase of rapid filling with variable LV pressure.
The peak negative MVG is thus a novel indicator of
auxotonic relaxation and may prove useful as a predictor of
diastolic dysfunction characterized by increased stiffness and
prolonged active relaxation.
Although LV filling does not occur during isovolumic
relaxation, the process that determines the rate of decrease
in pressure during isovolumic relaxation influences ventric-
ular filling after opening of the mitral valve (22,23). For the
first 30 to 40 ms after mitral valve opening, relaxation of LV
wall tension causes the LV pressure to fall (24), thereby
generating a pressure gradient and resulting in rapid filling.
After diastasis, atrial contraction increases the atrial pressure
and propels blood into the left ventricle. Therefore, LV
isovolumic relaxation influences the period of auxotonic
relaxation, during which the peak negative MVG occurs;
this period also influences the entire LV filling performance.
Both tau and peak negative dP/dt derived from invasive
techniques are well established as important clinical and
research tools for evaluation of LV relaxation abnormalities
(2,19,22). The peak negative dP/dt is affected by loading
conditions. Although tau is not significantly influenced by
preload alterations within a physiologic range (25), it is
estimated from the slope of the natural logarithm of the
pressure-time relation, reflecting the descending curve of
LV dP/dt, and corresponds to only the first period of the
isovolumic phase. The peak negative MVG reflects the
auxotonic relaxation phase, which is affected by both LV
active relaxation and passive stiffness. Our findings are
consistent with previous observations showing that the early
velocity of the mitral annulus obtained by TDI reflects
PAWP, behaves as a preload-independent index of LV
relaxation, and may be used to estimate LV filling pressure
(26,27).
Peak negative MVG in HCM patients. The peak nega-
tive MVG was significantly smaller in patients with HCM
than in control subjects, even though systolic performance
was similar in both groups. The cutoff value of the normal
peak negative MVG was 3.2/s. The LVEDP and PAWP
were significantly higher and tau was significantly prolonged
in HCM patients compared with controls. The LVEDP,
PAWP, and tau are widely used as indexes of diastolic
function (2,17,18,28) and were shown to be inversely
correlated with peak negative MVG in the present study.
The MVG is derived from the regression line for the
transmural velocity profile rather than from the endocardial
and epicardial point velocity difference (8,9). The pathologic
features of HCM, which include fibrosis and disarray of the
myocardium resulting in diminished ventricular compliance
(1,15), impaired relaxation, and increased LVEDP and
PAWP, are responsible for the deterioration in the dynam-
ics of myocardial thickening and thinning. Hence, the
reduction in peak negative MVG may provide insight into
the pathogenesis of HCM.
Clinical implications. Diastolic heart failure accounts for
30% to 50% of all cases of heart failure with preserved LV
systolic function, and it has become recognized as a separate
clinical entity (29–31). It has thus become important to
establish precise indexes for assessment of diastolic function.
Peak negative MVG has previously been suggested as an
indicator of LV relaxation (11–13) that is relatively inde-
pendent of changes in preload (11,12,14). However, we
have shown that the peak negative MVG provides informa-
tion related to LV diastolic performance, including both
active relaxation and passive stiffness, and thus may prove of
use as a noninvasive indicator of global LV diastolic func-
tion. Serial measurements of peak negative MVG should
prove valuable in the follow-up of patients with progressive
diastolic dysfunction.
Study limitations. Both the pattern and the extent of LV
hypertrophy vary greatly among patients with HCM, al-
though abnormalities of global diastolic filling are largely
independent of the extent and distribution of myocardial
hypertrophy (32). It remains unclear, however, whether
diastolic filling varies among different regions of the left
ventricle and whether it is influenced by the thickness of the
septum (33). In addition, wall motion abnormalities such as
asynchrony that might result from ischemic events may
influence the accuracy of the determination of peak negative
MVG. For patients either with regional asynergy due to
ischemic events or with asymmetric hypertrophy, the eval-
uation of global LV diastolic abnormalities solely from the
MVG of the posterior wall will provide insufficient infor-
mation. Development of angle-independent, two-
dimensional TDI that would allow both examination of all
segments of the LV wall and comparison of regional
diastolic function is awaited in the near future.
We required a sufficient number of control subjects to
determine the cutoff value of peak negative MVG for
differentiation between HCM patients and normal individ-
uals with a receiver operating characteristic curve. Given
that it was not ethically justified to perform invasive mea-
surements with healthy subjects, in addition to the 26
controls who underwent cardiac catheterization, we in-
cluded 21 control subjects who did not undergo this
procedure in the determination of the cutoff value.
Mitral annular velocity correlates with left atrial pressure
and mean PAWP, and this can be used to estimate LV
filling pressure (26,27). Also, LVEDP can be evaluated
from the relation of mitral A-wave duration to pulmonary
vein A-wave duration (34,35). Further studies are required
to compare the reliability of estimation of LVEDP or
PAWP from peak negative MVG and from other nonin-
vasive indexes, not only in patients with HCM but also
more generally in individuals with diastolic dysfunction.
Conclusions. Our results suggest that the peak negative
MVG is an indicator of global LV diastolic function,
reflecting the process of auxotonic relaxation, and provides
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information about both passive stiffness and active relax-
ation. It should therefore prove to be a useful index in the
follow-up of patients with progressive diastolic dysfunction
secondary to HCM.
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